I don't think that's fair. There may be some tha

I don't think that's fair. There may be some that are blindly optimistic, but most are not.

I have said before that I have become less optimistic. Primarily because of the failures if and around CD12, and our apparent inability to retain good people.

With that said, I still very much believe in this molecule and it seems that we are making progress in several areas.

I am watching closely to the BLA refiling and the progression of enrollment in Brazil. I am also very curious to see how quickly we can get the long haulers trial going.

These all have substantial value and the success (or failure) in these areas will forever change the direction of this company regardless of who is in charge. It seems to me that a good deal if the progress in these areas will occured before the shareholders meeting.

I want to hear all sides. This is a critical time for Cytodyn.